Risk group-High risk Posts on Medivizor
Navigation Menu

Risk group-High risk Posts on Medivizor

Searching for participants with leukemia and lymphoma to try a new treatment before stem cell transplantation

Posted by on Jun 29, 2019 in Leukemia | 0 comments

In a nutshell This study will investigate the effects of high-pressure oxygen on the transplant of umbilical cord blood stem cells in patients with blood cancers. The main outcome that will be measured is the time it takes for white blood cells to recover after treatment. This trial is recruiting in New York, US. The details Stem cell transplant (SCT)...

Read More

A long term follow-up study of young people with acute lymphoblastic leukemia.

Posted by on Mar 20, 2019 in Leukemia | 0 comments

In a nutshell This study examined the long-term effectiveness of different treatment strategies for acute lymphoblastic leukemia (ALL) in young people. This study concluded that augmented treatment for rapid early responders was most beneficial, with improved survival at 10 years.  Some background ALL is a cancer of the bone marrow. It leads to...

Read More

Is busulfan a useful drug to improve successful transplantation in the treatment of acute leukemia?

Posted by on Jun 26, 2018 in Leukemia | 0 comments

In a nutshell This study looked at the effect of using busulfan to delete blood cancer cells from the system before replacing them with normal cells in the treatment of leukaemia. The study found that busulfan therapy was effective in removing blood cancer cells before replacement, in the treatment of high-risk acute leukaemia. Some background Acute...

Read More

A review of CAR-T cell therapy for CLL

Posted by on Jan 27, 2018 in Leukemia | 0 comments

In a nutshell This study reviewed CAR-T cell therapy, a new type of immunotherapy, for chronic lymphocytic leukemia (CLL). Some background Chimeric antigen receptor (CAR) T-cell therapy helps the immune system to fight cancer cells. In this treatment, immune cells (the T-cells) are removed from the blood. The T-cells are then genetically modified...

Read More

Is stem cell transplantation a viable option among AML patients who are not in remission?

Posted by on Sep 3, 2017 in Leukemia | 0 comments

In a nutshell This study examined stem cell transplant outcomes across acute myeloid leukemia (AML) patients with different disease status. Researchers reported superior survival after a stem cell transplant among patients in second complete remission.  Some background Stem cell transplantation is considered the most effective therapy for...

Read More